BTIG: Maintaining the Rani Therapeutics Hldgs (RANI.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $7.00 to $14.00.
BTIG：维持Rani Therapeutics Hldgs(RANI.US)评级，由买入调整至买入评级, 目标价由7.00美元调整至14.00美元。
BTIG: Maintaining the Rani Therapeutics Hldgs (RANI.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $7.00 to $14.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.